Latest News Archive
Please select Category, Year, and then Month to display items
![]()
The Vice-Chancellor and Principal of the University of the Free State, Prof Francis Petersen, is pleased to invite you to the launch of the Artists in Residency Programme. This event marks the exciting start of a new initiative at the university.
We are honored to have Mike van Graan, a distinguished independent artist and playwright, as our inaugural artist and playwright in residence. Van Graan boasts an impressive career, having authored 36 plays and contributing significantly to the cultural landscape. His expertise extends beyond playwriting, encompassing cultural policy, artist network development (both locally and across Africa), and advocacy work. Notably, he held leadership positions within esteemed organisations such as Arterial Network, the African Arts Institute, and the STAND Foundation. Van Graan's dedication to cultural activism and artistic creation is widely recognised.
Please join us for this momentous occasion:
Date: Thursday 27 June 2024
Time: 15:00-17:00 (followed by a cocktail reception)
Venue: Scaena Theatre, UFS Bloemfontein Campus
For further information, contact Alicia Pienaar at pienaaran1@ufs.ac.za.
Programme highlights include:
- Staged Reading: An excerpt from Return of the Ancestors, a play that pays homage to the satirical South African political play, Woza Albert, explores themes of democracy and sacrifice through the return of figures such as Steve Biko and Neil Aggett.
- Closed Premiere: The Good White, set against the backdrop of the 2015/16 student protests in South Africa, delves into contemporary issues such as race, social justice, and the complexities of human relationships.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”